The new unit will be built with INEOS’ latest process technology and aims to substantially improve the sustainability of our supply to our customers and reduce our environmental impact
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Iktos and Teijin Pharma will collaborate in developing new AI technology aiming to bring further improvement and speed to the drug design process
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
Ind-Ra maintains a neutral outlook for healthcare in FY23
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
The new facility is scheduled to start operation in the first half of 2024
Subscribe To Our Newsletter & Stay Updated
